Ningbo Dasky Life Science Co., Ltd.
Image 1
Company Profile
Company Culture
Organization
Quality Policy
Company Profile

Ningbo Dasky Life Science Co.Ltd.

was established in April 2019, the company is committed to all kinds of chronic disease detection and diagnosis and treatment equipment development, production and sales of integrated high-tech enterprises to facilitate patients to obtain self-health management guidance, to facilitate health care personnel and health management consultants to provide targeted diagnosis and treatment and guidance.

about

The company adheres to the belief of "pursuing excellence, accomplishing the extraordinary", focuses on the principle of "safety, effectiveness", and constantly researches and develops clinically applicable high and new medical device products; carries out the quality policy of "Quality Assurance, Reputation Supreme", and strives to produce "100% high-quality products". We implement the quality policy of "Quality Assurance and Credibility" and endeavor to produce "100% high quality products". The company has gathered a group of multi-level, high-quality professionals, relying on modern scientific management system, rigorous and efficient work style and perfect after-sales service system, forming a perfect system integrating research and development, production, sales, logistics and maintenance.

Over 20 years

Deep experience in the industry

2000+

Laboratory Purchasing Cooperation in Higher Education Institutions

50000m²

R&D Factory Integration

2023

China International Expo for Laboratory Medicine Instruments and Reagents (CACLP)

China Medical Equipment Fair (CMEF)

Not only that, Dasky is also working hard to build an ecosystem of chronic disease health services, research in early screening, early warning, intervention, care and other aspects of the disease, and continue to contribute to the development of China's health industry, intelligent biosensors, in-hospital POCT management system, cloud data open platform, cloud health management, chronic disease support system, chronic disease management center and healthcare management system. The company will focus on Internet+medical chronic disease management, develop a new model of chronic disease management, connect patients with health management services through intelligent biosensors, facilitate patients' access to self-health management guidance on the basis of data, and make it easier for healthcare personnel and health management consultants to provide targeted diagnosis and treatment and guidance.

 

We firmly believe that even a big enterprise cannot support an industry and without the soil for the healthy development of the industry, there is no guarantee for the sustainable development of the enterprise. We expect China's medical device industry to develop and grow rapidly, and we believe that our company will grow into an outstanding enterprise while contributing to the development of China's medical device industry!

Development

  • 2019
    Company Establishes First Blood Glucose Meter Blood Glucose Test Strips Entering Clinical Trials

  • 2020
    Established Molecular Diagnostics Business
    Completed human pathogen level II biosafety laboratory
    The first virus preservation delivery reagent obtained European CE certificate
    Laboratory validation of new crown antigen detection reagents completed
    Passed TUV ISO13485 certification
    Completion of FDA 510K certification for virus preservation and delivery reagents
  • 2021

    COVID Antigen Detection Reagent Completes Netherlands Laboratory Clinic
    Obtained European CE2934 self-test certificate
    (Disposable sterile swabs obtained TUV CEO123 registration certificate)
    (Home use self-test blood glucose testing system live TUV CEO123 certificate of registration)
    (More than one hundred kinds of culture media, cell and tissue transporters, and preservation solutions have been produced and transformed successively.)

  • 2022

    COVID Antigen Detection Reagent Passes U.S. Clinical Trial
    The first pet fast-track product--Small virus antigen detection kit launched
    The first animal husbandry rapid test product - pig cancer antigen detection kit was launched
    The first rapid drug testing product - methamphetamine rapid test kit was launched

  • 2023

    Continuous Monitoring Ambulatory Glucose Meter CGM Completes Internal Clinical Trial
    Disposable Sterile Sampling Swabs Obtained Domestic Medical Device Registration Certificate
    Home-use blood glucose meter G-10 obtained domestic medical device registration certificate
    Blood Glucose Test Strip GS-10 obtained domestic medical device registration certificate (in vitro diagnostic reagent)

2023 Exhibition Schedule

Date Exhibition Name Location
March 19-22 Laboratory Analytical Instrumentation Pittsburgh, Philadelphia, USA
April 19-21 Southeast Asia International Medical & Pharmaceutical Exhibition Kuala Lumpur, Malaysia
May 14-17 China Medical Device Expo Shanghai, China
May 23-26 Sao Paulo International Medical Devices Exhibition Sao Paulo, Brazil
May 28-30 China International Medical Instruments & Reagents Expo Nanchang, China
August 16-18 Medical Device Expo Philippines Manila Philippines
September 6-8 Beijing Analytical Testing Conference & Exhibition Beijing, China
September 13-16 Vietnam International Pharmaceutical and Medical Equipment Exhibition Ho Chi Minh, Vietnam
October 18-21 Indonesia International Medical Equipment Exhibition, Hospital Supplies & Laboratory Equipment Exhibition Jakarta, Indonesia
November 13-16 Germany MEDICA Dusseldorf, Germany

2024 Exhibition Schedule

Date Exhibition Name Location
March 5-7 Guangzhou International Analytical Testing & Laboratory Equipment Exhibition & Technical Seminar Guangzhou, China
March 16-18 The 21st China International Expo for Laboratory Medicine and Blood Transfusion Instruments and Reagents CACLP Chongqing, China
April 11-14 The 89th China International Medical Equipment Fair (Spring) CMEF Shanghai, China
May 29-31 Beijing Experimental Instrument Exhibition Beijing, China
Nov 18-20 Analytics & Biochemistry Shanghai Shanghai, China
February 24-28 Laboratory Analytical Instrumentation Pittsburgh San Diego, USA
March 14-17 The 39th Korea International Hospital Medical Equipment Laboratory Healthcare Exhibition Seoul, Korea
April 17-19 The 24th East Africa Kenya International Medical Equipment Exhibition Nairobi, Kenya
April 23-26 Korea Laboratory Analysis & Biochemistry Technology Exhibition Seoul, Korea
May 21-24 Brazil International Medical Hospital Laboratory Healthcare Exhibition Sao Paulo, Brazil
June 19-21 39th Floridian International Medical FIME Miami, USA
July 10-12 Thailand International Medical Laboratory Exhibition Bangkok, Thailand
August 31st Vietnam International Medical Laboratory Exhibition Ho Chi Minh ,Vietnam
September 26-28 2024 Bangladesh International Medical Equipment Exhibition Dhaka, Bangladesh
October South Africa International Medical Laboratory Exhibition Johannesburg, South Africa
October 22nd Asia International Healthcare Exhibition Karachi, Pakistan
November MEDICA Germany Dusseldorf, Germany
Image 1
Company Profile
Company Culture
Organization
Quality Policy
Company Profile
about

Ningbo Dasky Life Science Co.Ltd.

was established in April 2019, the company is committed to all kinds of chronic disease detection and diagnosis and treatment equipment development, production and sales of integrated high-tech enterprises to facilitate patients to obtain self-health management guidance, to facilitate health care personnel and health management consultants to provide targeted diagnosis and treatment and guidance.

about

“ Excellence precision
Heslth care ”

The company adheres to the belief of "pursuing excellence, accomplishing the extraordinary", focuses on the principle of "safety, effectiveness", and constantly researches and develops clinically applicable high and new medical device products; carries out the quality policy of "Quality Assurance, Reputation Supreme", and strives to produce "100% high-quality products". We implement the quality policy of "Quality Assurance and Credibility" and endeavor to produce "100% high quality products". The company has gathered a group of multi-level, high-quality professionals, relying on modern scientific management system, rigorous and efficient work style and perfect after-sales service system, forming a perfect system integrating research and development, production, sales, logistics and maintenance.

Over 20 years

Deep experience in the industry

2000+

Laboratory Purchasing Cooperation in Higher Education Institutions

50000m²

R&D Factory Integration

2023

China International Expo for Laboratory Medicine Instruments and Reagents (CACLP)

China Medical Equipment Fair (CMEF)
Image 1 Image 1
Image 1

Not only that, Dasky is also working hard to build an ecosystem of chronic disease health services, research in early screening, early warning, intervention, care and other aspects of the disease, and continue to contribute to the development of China's health industry, intelligent biosensors, in-hospital POCT management system, cloud data open platform, cloud health management, chronic disease support system, chronic disease management center and healthcare management system. The company will focus on Internet+medical chronic disease management, develop a new model of chronic disease management, connect patients with health management services through intelligent biosensors, facilitate patients' access to self-health management guidance on the basis of data, and make it easier for healthcare personnel and health management consultants to provide targeted diagnosis and treatment and guidance.

We firmly believe that even a big enterprise cannot support an industry and without the soil for the healthy development of the industry, there is no guarantee for the sustainable development of the enterprise. We expect China's medical device industry to develop and grow rapidly, and we believe that our company will grow into an outstanding enterprise while contributing to the development of China's medical device industry!

Image 1

Development

  • 2019
    Company Establishes First Blood Glucose Meter Blood Glucose Test Strips Entering Clinical Trials

  • 2020
    Established Molecular Diagnostics Business
    Completed human pathogen level II biosafety laboratory
    The first virus preservation delivery reagent obtained European CE certificate
    Laboratory validation of new crown antigen detection reagents completed
    Passed TUV ISO13485 certification
    Completion of FDA 510K certification for virus preservation and delivery reagents
  • 2021

    COVID Antigen Detection Reagent Completes Netherlands Laboratory Clinic
    Obtained European CE2934 self-test certificate
    (Disposable sterile swabs obtained TUV CEO123 registration certificate)
    (Home use self-test blood glucose testing system live TUV CEO123 certificate of registration)
    (More than one hundred kinds of culture media, cell and tissue transporters, and preservation solutions have been produced and transformed successively.)

  • 2022

    COVID Antigen Detection Reagent Passes U.S. Clinical Trial
    The first pet fast-track product--Small virus antigen detection kit launched
    The first animal husbandry rapid test product - pig cancer antigen detection kit was launched
    The first rapid drug testing product - methamphetamine rapid test kit was launched

  • 2023

    Continuous Monitoring Ambulatory Glucose Meter CGM Completes Internal Clinical Trial
    Disposable Sterile Sampling Swabs Obtained Domestic Medical Device Registration Certificate
    Home-use blood glucose meter G-10 obtained domestic medical device registration certificate
    Blood Glucose Test Strip GS-10 obtained domestic medical device registration certificate (in vitro diagnostic reagent)

© Copyright © 2019 Ningbo Dasky Life Science Co., Ltd. All Rights Reserved. 浙ICP备11035535号-1

© Copyright © 2019 Ningbo Dasky Life Science Co., Ltd. All Rights Reserved. 浙ICP备11035535号-1